74 results on '"Cardoso, Rhanderson"'
Search Results
2. GlycA Levels Independently Predict Coronary Artery Calcium Incidence and Progression in the ELSA-Brasil Cohort (Brazilian Longitudinal Study of Adult Health)
3. Changes in use of preventive medications after assessment of chest pain by coronary computed tomography angiography: A meta-analysis
4. AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD
5. Early Initiation of PCSK9 Inhibitor Therapy Versus Placebo in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
6. Diagnostic Accuracy of ECG to Detect Left Ventricular Hypertrophy in Patients with Left Bundle Branch Block: A Systematic Review and Meta-analysis
7. How early can atherosclerosis be detected by coronary CT angiography? Insights from quantitative CT analysis of serial scans in the PARADIGM trial
8. Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion
9. Angiotensin Receptor–Neprilysin Inhibitor Effects on Atherosclerotic Cardiovascular Disease Events: A Meta-Analysis of Randomized Controlled Trials
10. Clinical outcomes of automatic algorithms in cardiac resynchronization therapy: Systematic review and meta-analysis
11. Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care
12. Non-Vitamin K Antagonists Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Valves: A Systematic Review and Meta-Analysis
13. Sacubitril/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction
14. Risk Markers for Limited Coronary Artery Calcium in Persons With Significant Aortic Valve Calcium (From the Multi-ethnic Study of Atherosclerosis)
15. Meta-Analysis of Duration of Dual Antiplatelet Therapy in Acute Coronary Syndrome Treated With Coronary Stenting
16. Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials
17. Applications of PET-MR Imaging in Cardiovascular Disorders
18. In-Hospital Management and Outcomes of Patients With Acute Myocardial Infarction and Influenza
19. Cardiac sympathetic denervation for refractory ventricular arrhythmias in patients with structural heart disease: A systematic review
20. A Clinician's Guide to Healthy Eating for Cardiovascular Disease Prevention
21. Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 2
22. Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 1
23. Kiosk 6R-TC-04 - Effect of Aficamten on Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The FOREST-HCM CMR Sub-study
24. Kiosk 4Q-TA-02 - A Case of Pleomorphic Leiomyosarcoma Mimicking Thrombus
25. Kiosk 4Q-TA-01 - A Case of a Papillary Fibroelastoma Mimicking Hemangioma
26. Kiosk 3Q-TA-01 - A Case of a Cardiac Calcified Amorphous Tumor Mimicking a Left Atrial Myxoma
27. Kiosk 3Q-FA-01 - A Case of a Synovial Cardiac Sarcoma Mimicking Pericardial Cyst
28. CASE-SB-02 - A Case of Cardiac Hemangioma Mimicking Paraganglioma
29. Chagas Cardiomyopathy is Associated With Higher Incidence of Stroke: A Meta-analysis of Observational Studies
30. Natural language processing to phenotype coronary computed tomography angiography: Development, validation, and initial results of a large multi-institution cohort
31. PROMISE MINIMAL RISK SCORE IN YOUNG INDIVIDUALS WITH MYOCARDIAL INFARCTION: FROM THE MGB YOUNG-MI REGISTRY
32. LIPOPROTEIN(A) AS A CARDIOVASCULAR RISK FACTOR AMONG PATIENTS WITH AND WITHOUT DIABETES MELLITUS: THE MASS GENERAL BRIGHAM LP(A) REGISTRY
33. EFFECT OF ANTIHYPERTENSIVE AGENTS ON RISK OF NEW-ONSET AND RECURRENT ATRIAL FIBRILLATION: A NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
34. THE ASSOCIATION OF IMMUNE-MEDIATED INFLAMMATORY DISEASE AND LIPOPROTEIN(A) WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG INDIVIDUALS WITH AND WITHOUT BASELINE ATHEROSCLEROTICCARDIOVASCULAR DISEASE: THE MASS GENERAL BRIGHAM LP(A) REGISTRY
35. ADVERSE CARDIOVASCULAR EVENTS AMONG YOUNGER AND OLDER PATIENTS REFERRED FOR CORONARY CTA: THE MASS GENERAL BRIGHAM CCTA REGISTRY
36. OPTIMAL TIMING FOR PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: A BAYESIAN NETWORK META-ANALYSIS
37. MP-453089-3 CLINICAL OUTCOMES OF AUTOMATIC AV AND VV INTERVAL ALGORITHMS IN CRT: SYSTEMATIC REVIEW AND META-ANALYSIS.
38. POLYPILL-BASED STRATEGY VERSUS USUAL CARE FOR SECONDARY CARDIOVASCULAR PREVENTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
39. REDUCTION OF STROKE AND REVASCULARIZATION WITH CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY VERSUS DIRECT INVASIVE CORONARY ANGIOGRAPHY IN STABLE PATIENTS WITH SUSPECTED CORONARY ARTERY DISEASE: A META-ANALYSIS OF RANDOMIZED TRIALS
40. ARTIFICIAL INTELLIGENCE-GUIDED CARDIAC MAGNETIC RESONANCE IMAGING AS A CLINICAL ROUTINE PROCEDURE LEADS TO SUBSTANTIAL REDUCTION OF SCAN TIME AND IMPROVEMENT OF IMAGING QUALITY. COMPARATIVE RESULTS OF 1,147 PATIENT STUDIES FROM A SINGLE US CENTER
41. HEMODYNAMIC AND CLINICAL OUTCOMES OF HYPOATTENUATING LEAFLET THICKENING AFTER TRANSCATHETER OR SURGICAL AORTIC VALVE REPLACEMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
42. CLINICAL OUTCOMES OF REDUCED LEAFLET MOTION AFTER SURGICAL OR TRANSCATHETER AORTIC VALVE REPLACEMENT: A META-ANALYSIS
43. DIAGNOSTIC PERFORMANCE OF ECG CRITERIA FOR LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH LEFT BUNDLE BRANCH BLOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS
44. CASE FROM CARDIO-RHEUMATOLOGY CLINIC: IMPORTANCE OF MULTI-MODALITY IMAGING IN ASSESSMENT OF A PATIENT WITH PSORIATIC ARTHRITIS
45. IMPACT OF TRICUSPID REGURGITATION ON MORTALITY: A META-ANALYSIS OF KAPLAN-MEIERDERIVED INDIVIDUAL PATIENT DATA
46. NON-VITAMIN K ANTAGONISTS VS. WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND TRANSCATHETER AORTIC VALVE REPLACEMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
47. The 2021 AHA/ACC/SCAI Coronary Artery Revascularization Recommendations: Need for Emphasis on Prevention and Future Considerations
48. B-PO02-062 IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AND OUTCOMES OF PATIENTS WITH VENTRICULAR ASSIST DEVICES: AN UPDATED META-ANALYSIS
49. NON-VITAMIN K ANTAGONISTS SHOULD BE PREFERRED OVER WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND BIOPROSTHETIC VALVES: A SYSTEMATIC REVIEW AND META-ANALYSIS
50. DUAL ANTIPLATELET THERAPY FOR 1 TO 3 MONTHS IS SUPERIOR TO 12 MONTHS AFTER CORONARY STENTING
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.